Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Research Article


 

Controlled Release Formulation of Indomethacin Prepared With Bee Glue Extracts

 

S Honary1*, P Ebrahimi2, F Naghibi3, M Chaigani1

1Mazandaran University of Medical Sciences, School of Pharmacy, Pharmaceutical Sciences Research Center, Sari, 2Gonbad Institute of Higher Education Center, P.O. Box 163, Gonbad, 3 Traditional Medicine & Materia Medica Research Center (TMRC) Shaheed Beheshti University of Medical Sciences, Tehran, Iran

For correspondence: E-mail: shonary@mazums0ac.ir, shonary@yahoo.com  Tel: 0098 912 145 2220

 

Received: 27 December 2010                                                           Revised accepted: 30 July 2011

 

Tropical Journal of Pharmaceutical Research, Oct 2011; 10(5): 543-550

http://dx.doi.org/10.4314/tjpr.v10i5.2

 

Abstract

 

Purpose: To prepare and evaluate new sustained release formulations of indomethacin based on extracts of propolis (bee glue).

Methods: Standardization of propolis (bee glue) extracts was performed by high performance liquid chromatography (HPLC) and determination of the values of fat and fixed oils. Several indomethacin capsule formulations (F1 - F18) containing varying amounts of chloroform (0.75 - 75 mg) and ethanol extracts (30 - 75 mg) of propolis were prepared. The dissolution rate of the formulations was evaluated by USP dissolution (rotating basket) method I  and the release data subjected to various kinetic models. Probable interaction between the drug and propolis extracts was studied by differential scanning calorimetry (DSC).

Results: The results show that, although the release rate of formulations F1 - F7 did not show any significant difference (p < 0.05) compared to F18 as blank, the other formulations did. DSC results indicate that incorporation of propolis extract in the formulations lowered indomethacin melting point by between 5 and 30 ºC, indicating interaction between the drug and the waxy extract. Kinetic analysis of the in vitro release data of the formulations showed that the best-fit drug release model varied with the drug:propolis extract ratio of the formulations. 

Conclusion: Formulation F13 (with equal proportion of drug and bee glue extract) came out best from the dissolution test for indomethacin extended-release capsules as it exhibited zero order kinetics.  This fpormulation is therefore suitable for further development as a matrix formulation for controlled  release.

 

Keywords: Propolis (bee glue), Indomethacin, Controlled release, Zero order kinetics, Waxy materials

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net